Health Article

News Hour: Current and forthcoming studies of vaccines to prevent HIV infection have created a new optimism that the long and challenging road to the development of such a vaccine has begun to take some promising...

News Hour: Human rights are personal to Martha Tholanah, an outspoken champion of equal rights for lesbian, gay, bisexual, and transgender people and for all people living with HIV. Following her early life experiences of violence at...

News Hour: Inspired by a steady decline in new HIV infections and AIDS-related deaths, the sustainable development goals call for ending the AIDS epidemic as a public health threat by 2030. However, the world is not...

News Hour: A meeting held from 4-6 July 2016, in South Africa’s Johannesburg, brought together a small group of the Partnership’s Adolescent and Youth constituency members. The aim of this meeting was to facilitate a decision...

News Hour: Anthem Blue Cross of California and Valley Radiotherapy Associates Medical Group (VRA) have developed a new agreement for a single episode-of-care payment for patients with a breast cancer diagnosis requiring radiation therapy treatment. The case...

News Hour: An inexpensive blood test could one day tell doctors whether an infection is caused by a virus or a bacteria, and help prevent unwarranted prescribing of antibiotics, researchers said on Wednesday, reports BSS. The...

News Hour: Halima cries as her mother Yagana lifts her up to be weighed. The one-year-old girl’s belly protrudes over legs that are barely more than paper-thin skin and bone. The baby has been treated for...

News Hour: About 60,000 people trying to flee Syria are trapped without aid in extremely harsh conditions near Jordan’s northeastern border, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today, calling for...

News Hour: GSK today announced the start of a phase I clinical trial with GSK3359609, an investigational inducibile T-cell costimulator (ICOS) agonist antibody. ICOS is a co-stimulatory receptor that enhances T-cell responses and results in an...

News Hour: Sanofi  announced that it has filed definitive consent solicitation materials with the U.S. Securities and Exchange Commission (“SEC”) seeking to remove and replace each member of Medivation, Inc.’s (NASDAQ: MDVN) Board of Directors with...